Research & Literature

[Criteria for the diagnosis of corticobasal degeneration].

Shimohata T, Aiba I, Nishizawa M

Brain and nerve = Shinkei kenkyu no shinpo 2015; (67(4)):513-23 doi:10.11477/mf.1416200168.

Corticobasal degeneration: clinical characteristics and multidisciplinary therapeutic approach in 26 patients.

Shehata HS, Shalaby NM, Esmail EH, Fahmy E

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2015; (36(9)):1651-7 doi:10.1007/s10072-015-2226-x.

Mutation analysis of C9orf72 in patients with corticobasal syndrome.

Anor CJ, Xi Z, Zhang M, et al.

Neurobiology of aging 2015; (36(10)):2905.e1-5.

Therapeutic interventions in parkinsonism: Corticobasal degeneration.

Marsili L, Suppa A, Berardelli A, Colosimo C

Parkinsonism & related disorders 2016; (22 Suppl 1()):S96-100.

Swallowing disturbances in the corticobasal syndrome.

Grunho M, Sonies B, Frattali CM, Litvan I

Parkinsonism & related disorders 2015; (21(11)):1342-8.

[Diagnoses of corticobasal syndrome and corticobasal degeneration].

Shimohata T, Aiba I, Nishizawa M

Rinsho shinkeigaku = Clinical neurology 2016; (56(3)):149-57 doi:10.5692/clinicalneurol.cn-000841.

FP-CIT- and IBZM-SPECT in Corticobasal Syndrome: Results from a Clinical Follow-Up Study.

Hammesfahr S, Antke C, Mamlins E, et al.

Neuro-degenerative diseases 2016; (16(5-6)):342-7 doi:10.1159/000443667.

Progressive Supranuclear Palsy and Corticobasal Degeneration: Pathophysiology and Treatment Options.

Lamb R, Rohrer JD, Lees AJ, Morris HR

Current treatment options in neurology 2016; (18(9)):42 doi:10.1007/s11940-016-0422-5.

[Networks involved in motor cognition : Physiology and pathophysiology of apraxia].

Martin M, Hermsdörfer J, Bohlhalter S, Weiss PH

Der Nervenarzt 2017; (88(8)):858-865 doi:10.1007/s00115-017-0370-7.

FDG-PET patterns associated with underlying pathology in corticobasal syndrome.

Pardini M, Huey ED, Spina S, et al.

Neurology 2019; (92(10)):e1121-e1135 doi:10.1212/WNL.0000000000007038.

Unraveling corticobasal syndrome and alien limb syndrome with structural brain imaging.

Albrecht F, Mueller K, Ballarini T, et al.

Cortex; a journal devoted to the study of the nervous system and behavior 2019; (117()):33-40 doi:10.1016/j.cortex.2019.02.015.

Botulinum toxin for the treatment of dystonia and pain in corticobasal syndrome.

Unti E, Mazzucchi S, Calabrese R, et al.

Brain and behavior 2019; (9(6)):e01182 doi:10.1002/brb3.1182.

Corticobasal degeneration: advances in clinicopathology and biomarkers.

Svenningsson P

Current opinion in neurology 2019; (32(4)):597-603 doi:10.1097/WCO.0000000000000707.

Chameleons and mimics: Progressive supranuclear palsy and corticobasal degeneration.

Mimuro M, Yoshida M

Neuropathology : official journal of the Japanese Society of Neuropathology 2020; (40(1)):57-67 doi:10.1111/neup.12590.

Cerebrovascular pathology presenting as corticobasal syndrome: An autopsy case series of "vascular CBS".

Koga S, Roemer SF, Kasanuki K, Dickson DW

Parkinsonism & related disorders 2019; (68()):79-84 doi:10.1016/j.parkreldis.2019.09.001.

Corticobasal degeneration.

Saranza GM, Whitwell JL, Kovacs GG, Lang AE

International review of neurobiology 2019; (149()):87-136 doi:10.1016/bs.irn.2019.10.014.

Alien limb in the corticobasal syndrome: phenomenological characteristics and relationship to apraxia.

Lewis-Smith DJ, Wolpe N, Ghosh BCP, Rowe JB

Journal of neurology 2020; (267(4)):1147-1157 doi:10.1007/s00415-019-09672-8.

Clinical Phenotypes in Corticobasal Syndrome with or without Amyloidosis Biomarkers.

Benvenutto A, Guedj E, Felician O, et al.

Journal of Alzheimer's disease : JAD 2020; (74(1)):331-343 doi:10.3233/JAD-190961.

Novel tau filament fold in corticobasal degeneration.

Zhang W, Tarutani A, Newell KL, et al.

Nature 2020; (580(7802)):283-287 doi:10.1038/s41586-020-2043-0.

Individual Brain Metabolic Signatures in Corticobasal Syndrome.

Cerami C, Dodich A, Iannaccone S, et al.

Journal of Alzheimer's disease : JAD 2020; (76(2)):517-528 doi:10.3233/JAD-200153.

FDG-PET Patterns Predict Amyloid Deposition and Clinical Profile in Corticobasal Syndrome.

Parmera JB, Coutinho AM, Aranha MR, et al.

Movement disorders : official journal of the Movement Disorder Society 2021; (36(3)):651-661 doi:10.1002/mds.28373.

Progressive Supranuclear Palsy and Corticobasal Degeneration.

Coughlin DG, Dickson DW, Josephs KA, Litvan I

Advances in experimental medicine and biology 2021; (1281()):151-176 doi:10.1007/978-3-030-51140-1_11.

The Significance of Vascular Pathogenesis in the Examination of Corticobasal Syndrome.

Dunalska A, Pikul J, Schok K, et al.

Frontiers in aging neuroscience 2021; (13()):668614 doi:10.3389/fnagi.2021.668614.

Best Practices in the Clinical Management of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Consensus Statement of the CurePSP Centers of Care.

Bluett B, Pantelyat AY, Litvan I, et al.

Frontiers in neurology 2021; (12()):694872 doi:10.3389/fneur.2021.694872.

Language Disorder in Progressive Supranuclear Palsy and Corticobasal Syndrome: Neural Correlates and Detection by the MLSE Screening Tool.

Peterson KA, Jones PS, Patel N, et al.

Frontiers in aging neuroscience 2021; (13()):675739 doi:10.3389/fnagi.2021.675739.

Neuropathology and emerging biomarkers in corticobasal syndrome.

Koga S, Josephs KA, Aiba I, et al.

Journal of neurology, neurosurgery, and psychiatry 2022; doi:10.1136/jnnp-2021-328586.

Palliative care in Parkinson disease and related disorders.

Corcoran J, Huang AH, Miyasaki JM, Tarolli CG

Handbook of clinical neurology 2023; (191()):107-128 doi:10.1016/B978-0-12-824535-4.00017-3.

The Rossy Progressive Supranuclear Palsy Centre: Creation and Initial Experience.

Couto B, Fox S, Tartaglia MC, et al.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2023; (50(6)):845-852 doi:10.1017/cjn.2022.332.

Clinicoradiologic and Neuropathologic Evaluation of Corticobasal Syndrome.

Shir D, Pham NTT, Botha H, et al.

Neurology 2023; (101(3)):e289-e299 doi:10.1212/WNL.0000000000207397.

The prevalence and incidence of progressive supranuclear palsy and corticobasal syndrome: a systematic review and meta-analysis.

Lyons S, Trépel D, Lynch T, et al.

Journal of neurology 2023; (270(9)):4451-4465 doi:10.1007/s00415-023-11791-2.

[18F]-FDopa positron emission tomography imaging in corticobasal syndrome.

El Ouartassi A, Giordana C, Schiazza A, et al.

Brain imaging and behavior 2023; (17(6)):619-627 doi:10.1007/s11682-023-00789-z.

Pathomechanisms of cognitive and behavioral impairment in corticobasal degeneration.

Jellinger KA

Journal of neural transmission (Vienna, Austria : 1996) 2023; (130(12)):1509-1522 doi:10.1007/s00702-023-02691-w.

The Role of Dual-Phase 18 F-FP-CIT PET to Early Diagnosis of Corticobasal Syndrome.

Kim MS, Park DG, Shin IJ, et al.

Clinical nuclear medicine 2024; (49(2)):124-130 doi:10.1097/RLU.0000000000004979.

Clinical course of pathologically confirmed corticobasal degeneration and corticobasal syndrome.

Aiba I, Hayashi Y, Shimohata T, et al.

Brain communications 2023; (5(6)):fcad296 doi:10.1093/braincomms/fcad296.

Frequency and outcomes of gastrostomy insertion in a longitudinal cohort study of atypical parkinsonism.

Kobylecki C, Chelban V, Goh YY, et al.

European journal of neurology 2024; (31(6)):e16258 doi:10.1111/ene.16258.

Progression to corticobasal syndrome: a longitudinal study of patients with nonfluent primary progressive aphasia and primary progressive apraxia of speech.

Garcia-Guaqueta DP, Botha H, Utianski RL, et al.

Journal of neurology 2024; (271(7)):4168-4179 doi:10.1007/s00415-024-12344-x.

Pick's Disease Presenting as Tremulous Parkinsonism with Limited Levodopa Response-A Rare Cause of Corticobasal Syndrome.

Bhattacharjee S, Scotton W, Djoukhadar I, et al.

Movement disorders clinical practice 2024; (11(8)):1025-1029 doi:10.1002/mdc3.14125.

Comparing classic-onset corticobasal syndrome to speech/language-onset corticobasal syndrome.

Garcia-Guaqueta DP, Stephens YC, Ali F, et al.

Parkinsonism & related disorders 2024; (125()):107025 doi:10.1016/j.parkreldis.2024.107025.

Expanding the Spectrum of GBA1-Associated Neurodegenerative Diseases in an Italian Family.

Sorrentino C, Dati G, Cuoco S, et al.

Movement disorders clinical practice 2024; (11(8)):1030-1034 doi:10.1002/mdc3.14146.

Phenotypic and Positron Emission Tomography with [18F]fluordeoxyglucose (FDG PET) differences in corticobasal syndrome: comparison of two cases.

Beltrão TW, Maranhão EBA, Correia VAG, et al.

Dementia & neuropsychologia 2024; (18()):e20230085 doi:10.1590/1980-5764-DN-2023-0085.

Conventional magnetic resonance imaging key features for distinguishing pathologically confirmed corticobasal degeneration from its mimics: a retrospective analysis of the J-VAC study.

Sakurai K, Tokumaru AM, Yoshida M, et al.

Neuroradiology 2024; (66(11)):1917-1929 doi:10.1007/s00234-024-03432-w.

Clinical characteristics of Japanese patients with corticobasal degeneration.

Tahara D, Tahara N, Akagi A, et al.

Journal of the neurological sciences 2024; (466()):123212 doi:10.1016/j.jns.2024.123212.

Legumain/asparaginyl endopeptidase-resistant tau fibril fold produces corticobasal degeneration-specific C-terminal tau fragment.

Taniguchi D, Shimonaka S, Imtiaz A, et al.

Neurobiology of disease 2024; (201()):106686 doi:10.1016/j.nbd.2024.106686.

Distinct spatiotemporal atrophy patterns in corticobasal syndrome are associated with different underlying pathologies.

Scotton WJ, Shand C, Todd EG, et al.

Brain communications 2025; (7(2)):fcaf066 doi:10.1093/braincomms/fcaf066.

Progressive Supranuclear Palsy and Corticobasal Syndrome.

McFarland NR

Continuum (Minneapolis, Minn.) 2025; (31(4)):1023-1049 doi:10.1212/cont.0000000000001607.

Corticobasal degeneration preceded by cognitive impairment and apathy: An autopsy case report.

Hirose S, Kobayashi R, Hatakeyama S, et al.

PCN reports : psychiatry and clinical neurosciences 2025; (4(3)):e70174 doi:10.1002/pcn5.70174.

Cortical hyperexcitability in corticobasal syndrome as revealed by giant somatosensory evoked potentials.

Tojima M, Sawamura M, Shima A, et al.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2025; (178()):2110977 doi:10.1016/j.clinph.2025.2110977.

A Biomarker-Based Classification of Corticobasal Syndrome.

Palleis C, Bernhardt AM, Weidinger E, et al.

Movement disorders : official journal of the Movement Disorder Society 2026; (41(1)):129-142 doi:10.1002/mds.70070.

Clinical Framework for Motor Rehabilitation in Parkinsonism: Integrating Individualized and Syndrome-Specific Approaches.

Kim DY

Brain & NeuroRehabilitation 2025; (18(3)):e6 doi:10.12786/bn.2025.18.e6.

The Paper-Toss Test: enhancing bedside recognition of corticobasal syndrome.

Lueg G, Duning T, Hobert MA, et al.

Frontiers in neurology 2025; (16()):1634177 doi:10.3389/fneur.2025.1634177.

Voice and Speech in Atypical Parkinsonian Disorders.

Rodriguez-Porcel F, Ali F, Bruno M, et al.

Movement disorders clinical practice 2026; (13(8)):1848-1860 doi:10.1002/mdc3.70515.

Percutaneous endoscopic gastrostomy in atypical parkinsonian syndromes: survival and aspiration outcomes from a retrospective international cohort.

Ruttle T, Jones E, Towns C

The New Zealand medical journal 2026; (139(1628)):40-49 doi:10.26635/6965.7117.

Real-world evaluation of Armstrong's criteria in corticobasal degeneration: Phenotypic overlap and diagnostic challenges.

Morihara R, Nomura E, Osakada Y, et al.

Parkinsonism & related disorders 2026; (145()):108229 doi:10.1016/j.parkreldis.2026.108229.

From clinical phenotypes to molecular stratification: early differential diagnosis of four-repeat tauopathies.

Bernhardt AM, Höglinger GU, Palleis C

Frontiers in aging neuroscience 2026; (18()):1801615 doi:10.3389/fnagi.2026.1801615.

Limb apraxia in Parkinson's disease and atypical parkinsonian syndromes: a systematic review.

Smaragdaki E, Stamelos I, Tsolaki M, et al.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2026; (47(8)).

A Randomized Controlled Trial of Dual Upper-Extremity Training [DUET]: Combining Neurologic Music Therapy® with Noninvasive Brain Stimulation for Upper-Limb Performance in Corticobasal Syndrome.

Kang K, Sterner I, Bakhshi S, et al.

Movement disorders clinical practice 2026; doi:10.1002/mdc3.70734.

Prognostic factors of survival in corticobasal syndrome and corticobasal degeneration: A scoping review.

Saim MS, Al-Kazzaz H, Ahmad H

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2026; (47(8)).